Health Care/Hospital

CureApp Named to the 2020 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups

NEW YORK, Aug. 24, 2020 /PRNewswire/ -- CB Insights today named CureApp to its second annualDigital Health 150 ranking, which showcases the 150 most promising private digital healt...

2020-08-24 20:16 2177

WPI-MANA Team: New Solid Materials Enable Broader Application of Medical Gases

TSUKUBA, Japan, Aug. 24, 2020 /PRNewswire/ -- Hydrogen sulfide (H2S) and nitric oxide (NO) are gases with useful bio-activities, such as anti-oxidation, anti-inflammation and vasodilation. H2S is an ingredient in hot springs and long known to have positive effects on the skin and cardiovascular s...

2020-08-24 14:00 1592

Adlai Nortye Announces First Patient Dosed in Phase 1b Clinical Trial of AN0025 (EP4 Antagonist) in Combination with Merck's KEYTRUDA® (pembrolizumab) for Advanced Solid Tumors

NORTH BRUNSWICK, N.J., Aug. 24, 2020 /PRNewswire/ -- Adlai Nortye Ltd. ("Adlai Nortye"), a global clinical-stage biopharmaceutical company today announced that the first patient has been dosed in a phase1b clinical trial (AN0025S0103) to evaluate AN0025, an investigational, potentially first in c...

2020-08-24 13:13 1544

South Korea's KT Develops AI-Based COVID-19 Research

SEOUL, South Korea, Aug. 20, 2020 /PRNewswire/ -- KT Corp. (KRX: 030200; NYSE: KT),South Korea's largest telecommunications company, is developing a COVID-19 infection risk assessment model, using its artificial intelligence (AI) and Big Data-based digital contact tracing technology, adding to gl...

2020-08-20 21:00 8752

CARsgen Therapeutics Receives IND Clearance from the NMPA for CT041 CLDN18.2-CAR-T Cells

SHANGHAI, Aug. 20, 2020 /PRNewswire/ -- CARsgen Therapeutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced that the National Medical Products Administration (NMPA) has cleared its Investigational New Drug (IND) application for the first-in-class drug candidate CT041, auto...

2020-08-20 18:32 4479

111, Inc. Announces Second Quarter 2020 Unaudited Financial Results

SHANGHAI, Aug. 20, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a company dedicated to digitally connecting patients with drugs and healthcare services inChina, today announced its unaudited financial results for the second quarter endedJune 30, 2020. Second Quarter 2020...

2020-08-20 16:35 11611

111, Inc. Announces New Capital Injection and Strategic Plan to Expand Access to China's Capital Markets

* Completion of new capital injection in principal subsidiary Yao Fang Shanghai * Initiation to list shares of principal subsidiary Yao Fang Shanghai on the STAR Market * 111 firmly committed to maintaining Nasdaq listing status SHANGHAI, Aug. 20, 2020 /PRNewswire/ -- 111, Inc. ("111" or th...

2020-08-20 16:30 9561

PharmAbcine announces the execution of a Material Cooperative Research and Development Agreement (MCRADA) with the NIH to evaluate the efficacy of PMC-403 to treat SCLS

DAEJEON, South Korea, Aug. 18, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a Materials Cooperative Research and Development Agreement (MCRADA) with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), in whic...

2020-08-18 21:00 8683

Global Cord Blood Corporation to Report First Quarter Fiscal 2021 Financial Results

HONG KONG, Aug. 18, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release financial results fo...

2020-08-18 19:00 3939

Koichiro Matsumoto Appointed President/CEO of Bushu Pharmaceuticals Ltd.

KAWAGOE, Japan, Aug. 18, 2020 /PRNewswire/ -- In response to requests for a professional contract development and manufacturing organization (CDMO) partner inAsia that can better meet the needs and challenges of the global market, Bushu Pharmaceuticals Ltd. (hereinafter "Bushu Pharma") appointed ...

2020-08-18 14:00 1792

China Biologic Reports Financial Results for the Second Quarter of 2020

BEIJING, Aug. 17, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its unaudited financial results for the second quarter of 2020. Second Quart...

2020-08-18 04:30 10016

I-Mab Announces First Patient Dosed in Phase 1b Study of Plonmarlimab in Rheumatoid Arthritis in China

SHANGHAI and GAITHERSBERG, Md., Aug. 17, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first patient has been dosed with plonmarlimab ...

2020-08-17 20:00 3614

CARsgen Announces the Publication of a Novel CAR-T Technology that Improves the Efficacy of CAR-T cells Against Solid Tumors without Requiring Preconditioned Lymphodepletion

SHANGHAI, Aug. 17, 2020 /PRNewswire/ -- CARsgen Therapeutics, a leader in developing novel CAR-T cell therapies against solid tumors, today announced its publication of the 7×21 CAR-T technology in CLINICAL CANCER RESEARCH. The article is titled "Coexpression of IL-7 and CCL21 increases efficacy ...

2020-08-17 18:00 4175

China Jo-Jo Drugstores Reports First Quarter 2021 Financial Results

HANGZHOU, China, Aug. 14, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its fina...

2020-08-14 21:00 8043

China Pharma Holdings, Inc. Reports Second Quarter 2020 Financial Results

HAIKOU CITY, China, Aug. 14, 2020 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the qu...

2020-08-14 18:30 6011

Bushu Pharmaceuticals Announces Major Expansion Program

KAWAGOE, Japan, Aug. 14, 2020 /PRNewswire/ -- - Japan's Premier CDMO Will Invest $100m to Expand Capacity and Portfolio - Bushu Pharmaceuticals Ltd., one of Japan's largest contract manufacturers of pharmaceutical products, announced onAugust 14 a major capital program costing $100 million to ex...

2020-08-14 14:00 2643

Hankyung.com's introduces: "Seoul Made" PPE kits, targeting US Market

SEOUL, South Korea, Aug. 13, 2020 /PRNewswire/ -- "Seoul Made" PPE kits designed with Korean cultural themes and made by small businesses inSeoul, was delivered to New York on August 13th With many stakeholders of New Jersey, New York, Brooklyn, Chamber of Commerce, and other related agencies e...

2020-08-14 08:00 1979

WuXi AppTec Achieved Strong Growth in First-Half of 2020 with China Sites Resuming Full Operations

WuXi AppTec Second-Quarter 2020 Results Revenue Up 29.4% YoY to RMB4,044 Million Net Profit Attributable to Owners of the Company Up 111.0% YoY to RMB1,414 Million Diluted EPS Up 110.3% YoY to RMB0.61 Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 43.1% YoY toRMB942 Million...

2020-08-13 16:49 5175

United Imaging, Debuting at AHRA as a Gold Sponsor, Announces FDA Clearance of Its Latest Deep Learning Reconstruction Technology, uAI HYPER DLR

HOUSTON, Aug. 11, 2020 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, has received FDA clearance for uAI HYPER DLR (Deep Learning Reconstruction), an advanced image processing function intended to reduce the noise of fluorodeoxyglucose (FDG...

2020-08-12 00:00 1858

CPHI to Hold Second Quarter 2020 Earnings Conference Call On Friday August 14, 2020 at 8:30 a.m. ET

HAIKOU CITY, China, Aug. 11, 2020 /PRNewswire/ -- China Pharmaceutical Holdings Limited (NYSE American: CPHI) ("China Pharma" or "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it plans to hold its 2n...

2020-08-11 22:10 6057
1 ... 257258259260261262263 ... 283